SCHEMBL20660740

SCHEMBL20660740

FC(F)(F)c1ccc2nc(Cl)ncc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 2/20 0.40
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
TRPV4 Q9HBA0 1/20 0.38
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33
XPO1 O14980 1/20 0.33
NFKB1 P19838 7/20 0.33
ATF1 P18846 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20660682 0.76 NT5E (0.44) NT5ETRPV4PIK3CDPIK3CAPIK3CB
SCHEMBL31405448 0.74 ALDH1A1 (0.37) PIK3CDKDM4EALDH1A1SMN1; SMN2EGFR
SCHEMBL1320635 0.74 ALDH1A1 (0.37) PIK3CDKDM4EALDH1A1SMN1; SMN2EGFR
SCHEMBL22057382 0.71 CYP1A2 (0.41) KDM4EALDH1A1SMN1; SMN2EGFR
SCHEMBL20660629 0.70 NT5E (0.37) NT5EGABRA1GABRG2GABRB3GABRA3
SCHEMBL17959 0.70 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA3
SCHEMBL31038939 0.70 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA3
SCHEMBL30876122 0.69 TGFBR1 (0.48) GABRA1GABRG2GABRB3GABRA3TRPV4
SCHEMBL20660771 0.69 NT5E (0.36) NT5EXPO1NFKB1ATF1KDM4E
SCHEMBL20660632 0.69 BACE1 (0.50) XPO1NFKB1ATF1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258354-B2 AhR modulators IDEAYA BIOSCIENCES, INC. (US) 2025-03-25 US disclosed
EP-3749669-B3 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2024-09-04 EP disclosed
CN-111683950-B AhR modulators 伊迪亚生物科学有限公司 2024-04-16 CN disclosed
EP-4219495-A1 AHR MODULATORS Ideaya Biosciences, Inc. (US) 2023-08-02 EP disclosed
EP-4219495-A1 AHR MODULATORS Ideaya Biosciences, Inc. (US) 2023-08-02 EP disclosed
EP-3749669-B1 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2023-03-08 EP disclosed
US-20230039955-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2023-02-09 US disclosed
US-20230039955-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2023-02-09 US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-10815250-B2 AhR modulators IDEAYA BIOSCIENCES, INC. (US) 2020-10-27 US disclosed
US-10815250-B2 AhR modulators IDEAYA BIOSCIENCES, INC. (US) 2020-10-27 US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
US-20190270754-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2019-09-05 US disclosed
US-20190270754-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2019-09-05 US disclosed
WO-2019156987-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-08-15 WO disclosed
WO-2019156987-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-08-15 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039955-A1 AhR MODULATORS AHR, ARNT, RORB NT5E 2896/4885GABRA1 1252/4885GABRG2 1539/4885
US-12258354-B2 AhR modulators AHR, ARNT, RORB NT5E 2923/4885GABRA1 1260/4885GABRG2 1543/4885
US-10815250-B2 AhR modulators AHR, ARNT, RORB NT5E 2923/4885GABRA1 1260/4885GABRG2 1543/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB NT5E 2796/4885GABRA1 1561/4885GABRG2 1084/4885
US-20190270754-A1 AhR MODULATORS AHR, ARNT, RORB NT5E 2923/4885GABRA1 1260/4885GABRG2 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.